Alerts will be sent to your verified email
Verify Email
SOTAC
|
Sotac Pharmaceutical
|
Denis Chem Lab
|
Bal Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-4.85 % | 9.0 % | 8.41 % |
|
5yr average Equity Multiplier
|
7.05 | 1.47 | 4.51 |
|
5yr Average Asset Turnover Ratio
|
1.3 | 1.43 | 1.01 |
|
5yr Avg Net Profit Margin
|
1.45 % | 4.26 % | 1.86 % |
|
Price to Book
|
0.0 | 1.59 | 1.73 |
|
P/E
|
17.13 | 15.97 | 18.76 |
|
5yr Avg Cash Conversion Cycle
|
3.3 Days | 6.01 Days | 27.6 Days |
|
Inventory Days
|
36.47 Days | 24.03 Days | 99.82 Days |
|
Days Receivable
|
72.11 Days | 68.4 Days | 115.65 Days |
|
Days Payable
|
136.32 Days | 83.6 Days | 154.91 Days |
|
5yr Average Interest Coverage Ratio
|
3.3 | 13.12 | 1.5 |
|
5yr Avg ROCE
|
19.17 % | 13.71 % | 19.2 % |
|
5yr Avg Operating Profit Margin
|
7.12 % | 11.05 % | 9.12 % |
|
5 yr average Debt to Equity
|
2.81 | 0.09 | 1.95 |
|
5yr CAGR Net Profit
|
116.49 % | 21.53 % | 8.78 % |
|
5yr Average Return on Assets
|
1.93 % | 6.28 % | 1.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.85 % | 38.98 % | 50.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -1.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sotac Pharmaceutical
|
Denis Chem Lab
|
Bal Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|